Featured Courses

Implementing Evidence-driven Individualized Treatment Plans within Morquio A Syndrome

1.5 AMA PRA Category 1 Credit(s)™

This CME symposium on the management of patients with Morquio A syndrome will provide updated information and guidelines concerning the early and accurate diagnosis as well as an earlier intervention to imporive patient outcomes. Recent advances...

2015 AAAAI Medical Meeting Reporter: Best Practices to Optimize Patient Outcomes in Asthma

1.0 AMA PRA Category 1 Credit(s)™

This CME program will provide practitioners with the most up-to-date information regarding patient management care in asthma.

Optimal Diagnostic and Therapeutic Strategies to Improve Patient Outcomes in Idiopathic Pulmonary Fibrosis

1.5 AMA PRA Category 1 Credit(s)™

Idiopathic pulmonary fibrosis (IPF) carries a high morbidity rate with patients often experiencing poor-quality of life due to significant impairments in their function in normal daily activities and independence. Given the devastating impact of IPF, there has been...

2014 SABCS Meeting Reporter: Recent Therapeutic Advancements and Patient Management Recommendations within Metastatic Breast Cancer

1.0 AMA PRA Category 1 Credit(s)™

This Medical Meeting Reporter will summarize and analyze critical scientific information from the 2014 San Antonio Breast Cancer Symposium (SABCS). SABCS is a significant professional organization of oncologists and strives to promote the highest caliber...

Opioid REMS Resource: Tools for Safe Prescribing in Chronic Pain Management

3.0 AMA PRA Category 1 Credit(s)TM
3.0 AANP Credits

This monograph will evaluate clinical guidelines for the use of opioids, including the FDA Opioid REMS requirements, and their impact on the management of chronic pain. This series of activities will also evaluate recommended opioid risk-reduction strategies...

Opioid REMS Webseries

up to 3.5 AMA PRA Category 1 Credit(s)TM
up to 3.5 AANP Credits

  • Tools for Assessing Patients and Initiating ER/LA Opioids
  • Tools for Effective Monitoring of Patients on ER/LA Opioids
  • Tools for Managing Potential Adverse Events and Avoiding Drug-Drug Interactions

Incorporating Antiplatelet Therapeutics into Individualized Treatment Plans for Patients with Acute Coronary Syndrome

1.0 AMA PRA Category 1 Credit(s)™

Mortality rates and hospital remissions among patients with Acute Coronary Syndrome (ACS) remain high. In order to reduce this number, decreasing the risk of recurrent atherothrombotic events using pharmacologic approaches is one of the main treatment...

Integrating Effective Therapeutic Strategies and Patient Management Tactics into Personalized Treatment Plans within COPD

1.0 AMA PRA Category 1 Credit(s)™

Currently, research and emerging data have made it possible for patients with Chronic Obstructive Pulmonary Disease (COPD) to attain successful management of the once considered to be irreversible and untreatable disease. Updated guidelines now provide...

Medical Meeting Reporter from the 2014 American Epilepsy Society Annual Meeting: Incorporating Antiepileptic Therapeutics to Address Seizure Complications within Epilepsy

1.0 AMA PRA Category 1 Credit(s)™

The 2014 American Epilepsy Society (AES) 68th Annual Meeting was held in Seattle, Washington. Research and clinical care professionals gather each year to present the most up-to-date research on antiepileptic therapeutic options and give insight into...

Current Evidence Regarding the Efficacy and Safety of Existing and Emerging Biological Agents for Managing Patients with SLE

1.0 AMA PRA Category 1 Credit(s)™

In this MediTalkTM activity, the expert faculty will review the safety and efficacy of new and emerging biological agents that target the innate and adaptive immune cells as well as cytokines in Systemic Lupus Erythematosus (SLE). The faculty will also provide...

Medical Meeting Reporter from the 2014 American Epilepsy Society Annual Meeting: The Role of Emerging Antiepileptic Therapeutics in the Treatment of Epilepsy

1.0 AMA PRA Category 1 Credit(s)™

The 2014 American Epilepsy Society (AES) 68th Annual Meeting was held in Seattle, Washington this year where professionals in the field gathered to present new and upcoming clinical research and treatment options for patients with epilepsy. Updates...

Breakthroughs in Understanding and Treating Chronic Idiopathic Constipation and Irritable Bowel Syndrome

1.0 AMA PRA Category 1 Credit(s)™

The latest in understanding and treating chronic idiopathic constipation (CIC) and irritable bowel syndrome (IBS) are presented in this CME activity. Participants will learn to differentiate these conditions from each other and other medical conditions...

Out with the Old? In with the New? Bad Bugs, New Drugs, and Antimicrobial Stewardship

1.0 AMA PRA Category 1 Credit(s)™

In this CME activity, learners will be provided with optimal strategies for managing hospital-acquired infections (HAIs) associated with multi-drug resistant organisms (MDROs) in light of the latest evidence and the current and anticipated antimicrobial...

Advanced Curriculum for Cystic Fibrosis: Integrating Genome-Driven Data with Patient-Centered Treatment Strategies

1.5 AMA PRA Category 1 Credit(s)™

Owing to the high frequency and serious nature of cystic fibrosis, the development of targeted therapies for the management of this disease has been an active area of research. Pharmaceuticals have recently been designed which with certain genetic...

Focus on Bone Health: Treating Osteoporosis, Preventing Fractures

1.0 AMA PRA Category 1 Credit(s)™

Osteoporosis, a growing health problem, has serious long-term consequences of the fractures that result from the weakened bone. These include interference with activities of daily living, loss of independence, debilitating pain, poor quality of life, and, notably...

Prescription Monitoring Programs An Important Tool to Decrease Diversion and Abuse of Opioids

0.5 AMA PRA Category 1 Credit(s)™

Prescription Drug Monitoring Programs (PDMPs), or Prescription Monitoring Programs (PMPs), are electronic databases that track the dispensing of controlled substances, including opioids. PDMPs have been shown to not only decrease diversion and...

Utilizing GLP-1 Receptor Agonists and Insulins: High-efficiency Therapies in the Optimal Management of Patients with Type 2 Diabetes

up to 1.0 AMA PRA Category 1 Credit(s)TM
up to 2.0 CBRN Contact Hours

In this MediTalk, leading experts in type 2 diabetes mellitus (T2DM) management will review the long recognized patient-, system-, and clinician-related barriers to insulin initiation and intensification and will provide strategies that have been...


Recent Multimedia Activities

Primary Care Perspectives: The Effective Use of Mealtime and Basal Insulin Regimens in Patients with Type 2 Diabetes

up to 1.0 AMA PRA Category 1 Credit(s)™

One of the many barriers that clinicians who manage patients with type 2 diabetes mellitus (T2DM) who may be appropriate for insulin therapy is to overcome the misguided fear that patients have regarding their potential risk for hypoglycemia....

A Scientific and Clinical Update on Current and Emergent Therapeutics within Multiple Sclerosis: A 2014 Joint ACTRIMS-ECTRIMS Meeting Reporter

1.0 AMA PRA Category 1 Credit(s)™

This Elsevier Medical Meeting Reporter presents and summarizes important multiple sclerosis presentations and abstracts from the Joint Meeting of the American and European Committees for Treatment and Research of Multiple Sclerosis (ACTRIMS...

Effective Management of Psoriasis and Psoriatic Arthritis: Insights on Current and Emerging Therapies and Enhanced Professional Collaboration

up to 1.5 AMA PRA Category 1 Credit(s)TM
up to 3.0 CBRN Contact Hours

In the first interactive MediTalk digital roundtable discussion in the series, the expert faculty will review the safety, efficacy, and limitations of the currently available therapies for managing patients with psoriasis and/or psoriatic arthritis (PsA). They will discuss...

Primary Care Strategies for the Management of Common Urological Disorders in Men

up to 1.0 AMA PRA Category 1 Credit(s)TM
up to 2.0 CBRN Contact Hours

Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), frequently referred to as LUTS/BPH, is a common urological disorder in men that negatively impacts their quality of life. Primary care management of LUTS/BPH begins...


Recent Courses

MRI plays an essential role in every aspect of MS: in addition to excluding other neurologic disorders, MRI is commonly used to document dissemination of lesions both in space (DIS) and time (DIT) based on established criteria. Beyond diagnosis, MRI can provide prognostic information for disease and disability progression, and can aid in...
The 2014 Joint ACTRIMS-ECTRIMS Meeting was hosted in Boston, Massachusetts and provided attendees with current information on the basic and clinical issues in multiple sclerosis research. Multiple sclerosis is a rapidly evolving field through its clinical trial data, research and guidelines on appropriate diagnostic techniques and strategies for...
Ocular surface disease (OSD) is very common disorder, which affects millions of Americans. OSD affects the cornea, conjunctiva, eye lids, meibomian glands, or pre-ocular tear film. The dysfunction of these components can result in damage to the ocular surface, which necessitates rapid recognition and intervention to prevent patients from suffering...
Managing the Critically-Ill Patient with Hyponatremia
  • AMA PRA Category 1 Credit(s)™
Hyponatremia is the most common electrolyte imbalance in hospitalized patients that is often misdiagnosed or undiagnosed due to its nonspecific symptoms. Early diagnosis and adequate treatment are crucial to prevent increased morbidity and mortality. Recently, targeted therapies known as vaptans have become available. Physicians need to understand...
A thorough family history evaluation remains a critical tool that helps identify those patients who are at risk for hereditary cancer. The American College of Obstetricians and Gynecologists (ACOG) recommends that all women receive a family history evaluation to screen for inherited risk, and that this information be regularly updated. Patients...